Medical conversation startup Abridge raises $12.5M

Astrata is Scaling Up Year-Round HEDIS® with NLP Insights

Astrata and Smile CDR Announce NCQA Certification for Next-Generation Digital Quality Measurement Engine

Elevance Health to Acquire Specialty Pharmacy BioPlus

UPMC Enterprises partners with data analytics company

Clearsense teams with UPMC to help unlock unstructured data

UPMC Enterprises Invests in Hashed Health, a Blockchain-Focused Health Care Venture Studio

New Investment in Infectious Disease Connect Fuels World-Class ID Telemedicine Services and Analytics

ID Connect Expands Clinical Decision Support within UPMC and Continues to Deliver ID Care Quality Improvements and Cost Reductions

New Study Suggests Tele-Infectious Diseases Care is an Effective Alternative to In-Person ID Care

UPMC Expands Relationship with Kyruus, Makes Investment in Provider Search and Scheduling Company

UPMC Tests Digital Health App for Surgery Patients

UPMC to Pilot Support App at Its Centers for Perioperative Care

UPMC, Redesign Health announce first company from partnership

UPMC piloting perioperative care app at three hospitals

UPMC, Redesign Health collaboration launches its first startup, app that prepares patients for surgery

App helps patients recover better after surgery

UPMC researchers use Realyze Intelligence technology to improve treatments for early-stage breast cancer patients

UPMC Leverages Artificial Intelligence to Improve Breast Cancer Treatment

Real-World Data Partnership Aims to Advance Cancer Treatment

UPMC spinoff works with Memorial Sloan Kettering to extract clinical insights from EHRs

UPMC, CVS Health and General Catalyst fund Redesign Health

UPMC, General Catalyst, Samsung, CVS Health join $65M funding round for healthcare company

Redesign Health scores $65M to create and launch more healthcare startups

Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies

Galapagos Acquires CellPoint And AboundBio

Galapagos to buy CellPoint, AboundBio to boost access to cell therapies

London-based LivaNova is picking up another Pittsburgh biotech firm

ALung acquired by London-based health care company

Following Luxturna and slate of eye disease approvals, Roche adds another ophthalmology partner for AAV gene therapies

Roche Inks Potential $1B AAV Vector Deal with Avista for Eye Disease

Roche tasks Avista with scAAVenging for better eye disease gene therapy vectors

Positive results for Cerevance’s Parkinson’s drug

Biotech Startup Cerevance Strikes Alzheimer’s Research Deal With Merck

Merck is back in Alzheimer’s saddle with $1B-plus Cerevance pact, years after dropping the BACE

A biotech startup gives Merck its next shot at treating Alzheimer’s

Astellas inks $180M deal to bolster undruggable mitochondria R&D

Astellas subsidiary to partner with Pittsburgh upstart for ‘undruggable’ proteins

Generian, Mitobridge (Astellas) Partner to Expand Playbook of what is Druggable

Exclusive: UPMC launches another biotech, rooted in the tumor microenvironment

Novasenta Inc., a U.S. startup biotech company focused on the discovery and validation of novel targets to develop cancer therapies, has completed $40 million in Series A financing.

Novasenta raises $40M in Series A financing

SparingVision Raises €75 Million Series B to Continue Building World-Leading Portfolio of Genomic Medicines for Ocular Diseases

Pitt and UPMC Enterprises partner to accelerate research commercialization and build Pittsburgh’s life sciences economy